Hydrochlorothiazide
CAS No. 58-93-5
Hydrochlorothiazide( HCTZ | NSC 53477 | SU 5879 )
Catalog No. M15175 CAS No. 58-93-5
Hydrochlorothiazide is a first line diuretic compound of the thiazide class.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydrochlorothiazide
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydrochlorothiazide is a first line diuretic compound of the thiazide class.
-
DescriptionHydrochlorothiazide is a first line diuretic compound of the thiazide class.(In Vitro):Hydrochlorothiazide belongs to thiazide class of diuretics. It reduces blood volume by acting on the kidneys to reduce sodium (Na) reabsorption in the distal convoluted tubule. The major site of action in the nephron appears on an electroneutral Na+-Cl co-transporter by competing for the chloride site on the transporter. By impairing Na transport in the distal convoluted tubule, hydrochlorothiazide induces a natriuresis and concomitant water loss. Thiazides increase the reabsorption of calcium in this segment in a manner unrelated to sodium transport. Additionally, by other mechanisms, Hydrochlorothiazide is believed to lower peripheral vascular resistance. (In Vivo):Hydrochlorothiazide (HCTZ; orally bygavage; 12.5 mg/kg/d; 8 weeks) has improved cardiac function, reduced cardiac interstitial fibrosis and collagen volume fraction, decreased expression of AT1, TGF-β and Smad2 in the cardiac tissues in adult male Sprague Dawley rats. In addition, hydrochlorothiazide reduces plasma angiotensin II and aldosterone levels. Furthermore, hydrochlorothiazide inhibits angiotensin II-induced TGF-β1 and Smad2 protein expression in the neonatal rat ventricular fibroblasts.
-
In Vitro——
-
In Vivo——
-
SynonymsHCTZ | NSC 53477 | SU 5879
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorCarbonic anhydrase| Potassium Channel
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number58-93-5
-
Formula Weight297.74
-
Molecular FormulaC7H8ClN3O4S2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 13 mg/mL (43.66 mM); DMSO: 60 mg/mL (201.51 mM)
-
SMILESC1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl
-
Chemical Name6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ran XW, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 Jul; 36(4):583-7.
molnova catalog
related products
-
hCAII-IN-9
hCAII-IN-9 is a potent carbonic anhydrase inhibitor with IC50 values of 1.18 μM for hCA II, 0.17 μM for hCA IX, and 2.99 μM for hCA XII. It is not blood-brain barrier permeable.
-
Methazolamide
Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma.
-
1,3-Diphenylurea
1, 3-Diphenylurea is involved with Epoxide hydrolase activity.
Cart
sales@molnova.com